143 related articles for article (PubMed ID: 37962551)
1. Optimal Conservative Therapy Use among Adult Cure Glomerulonephropathy Participants with IgA Nephropathy.
Rajasekaran A; Larkina M; Julian BA; Canetta PA; Roehm BA; Khalid M; Mariani LH; Rizk DV
Kidney360; 2023 Dec; 4(12):1763-1769. PubMed ID: 37962551
[TBL] [Abstract][Full Text] [Related]
2. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
3. High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review.
Chen H; Jin J; Cheng MJ; He L; Zhou W; Guo L; Niu ZZ; Liang XN; Zhu RF; Bai Y; Xu JS
Medicine (Baltimore); 2023 Jan; 102(3):e32698. PubMed ID: 36701698
[TBL] [Abstract][Full Text] [Related]
4. [Current developments in the treatment of chronic glomerulonephritis].
Sabo I; Gluhovschi G; Golea O
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(5):429-37. PubMed ID: 2881333
[No Abstract] [Full Text] [Related]
5. Significance of renal hyaline arteriolosclerosis and tubulo-interstitial change in IgA glomerulonephropathy and focal glomerular sclerosis.
Hotta O; Yoshizawa N; Oshima S; Takeuchi A; Kawamura O; Kondo S; Kubota T; Niwa H
Nephron; 1987; 47(4):262-5. PubMed ID: 3696327
[TBL] [Abstract][Full Text] [Related]
6. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
7. [Effects of tonsillectomy on juvenile nephritis, involving IgA nephropathy, purpura nephritis and chronic and persistent glomerulonephritis].
Maeda H; Amatsu H; Tsuda M
Nihon Jibiinkoka Gakkai Kaiho; 1986 Sep; 89(9):1167-71. PubMed ID: 3794853
[No Abstract] [Full Text] [Related]
8. Coexistence of IgA nephropathy and membranous nephropathy.
Kobayashi Y; Fujii K; Hiki Y; Chen XM
Acta Pathol Jpn; 1985 Sep; 35(5):1293-9. PubMed ID: 3909735
[TBL] [Abstract][Full Text] [Related]
9. Acute poststreptococcal glomerulonephritis superimposed on IgA nephropathy.
Lim BJ; Suh KS; Na KR; Lee KW; Shin YT
Clin Nephrol; 2008 Aug; 70(2):155-8. PubMed ID: 18793531
[TBL] [Abstract][Full Text] [Related]
10. [IgA nephropathy complicated by pre-eclamptic focal glomerular sclerosis].
Takeda S; Kida H; Takasawa K; Goshima S; Katagiri M; Yoshimura M; Yokoyama H; Abe T; Hattori N
Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):391-8. PubMed ID: 3230692
[No Abstract] [Full Text] [Related]
11. Superimposition of poststreptococcal acute glomerulonephritis on the course of IgA nephropathy.
Hiki Y; Tamura K; Shigematsu H; Kobayashi Y
Nephron; 1991; 57(3):358-64. PubMed ID: 2017279
[TBL] [Abstract][Full Text] [Related]
12. [IgA nephropathy with malignant hypertension].
Fukase S; Suzuki M; Goto T; Saito M; Yokoyama K
Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2473-5. PubMed ID: 12373860
[No Abstract] [Full Text] [Related]
13. Glomerulonephritis in ankylosing spondylitis.
Shu KH; Lian JD; Yang YF; Lu YS; Wang JY; Lan JL; Chou G
Clin Nephrol; 1986 Apr; 25(4):169-74. PubMed ID: 3516479
[TBL] [Abstract][Full Text] [Related]
14. IgA Nephropathy.
Rodrigues JC; Haas M; Reich HN
Clin J Am Soc Nephrol; 2017 Apr; 12(4):677-686. PubMed ID: 28159829
[TBL] [Abstract][Full Text] [Related]
15. Diffuse alveolar hemorrhage in IgA nephropathy: case series and systematic review of the literature.
Rajagopala S; Parameswaran S; Ajmera JS; Ganesh RN; Katrevula A
Int J Rheum Dis; 2017 Jan; 20(1):109-121. PubMed ID: 26845236
[TBL] [Abstract][Full Text] [Related]
16. Mesangial IgA nephropathy.
Kincaid-Smith PS
Br Med J (Clin Res Ed); 1985 Jan; 290(6462):96-7. PubMed ID: 3917739
[No Abstract] [Full Text] [Related]
17. Increase in proteinuria and/or microhematuria following upper respiratory tract infections in patients with IgA nephropathy.
Miura M; Tomino Y; Suga T; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1984 Jun; 9(2):139-45. PubMed ID: 6535307
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and outcomes in endocapillary proliferative IgA nephropathy.
Liu LJ; Li GT; Zhou Y; Lv JC; Zhang H
Nephron Clin Pract; 2010; 115(2):c161-7. PubMed ID: 20407276
[TBL] [Abstract][Full Text] [Related]
19. Overlapping IgA and membranous nephropathy.
Jennette JC; Newman WJ; Diaz-Buxo JA
Am J Clin Pathol; 1987 Jul; 88(1):74-8. PubMed ID: 3300266
[TBL] [Abstract][Full Text] [Related]
20. Alveolar hemorrhage in IgA nephropathy treated with plasmapheresis.
Afessa B; Cowart RG; Koenig SM
South Med J; 1997 Feb; 90(2):237-9. PubMed ID: 9042181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
